| Mankind Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
				
  | 
			 
				
  | 
			
				
  | 				
		
				
  | 
			
			 
				
  | 
			
			 
				
  | 
							
		
 
				
  | 
			
			
				
  | 
								
			
				
  | 
		
| Mar'2025 | Mar'2024 | Mar'2023 | Mar'2022 | Mar'2021 | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Equity Share Capital | 41.26 | 40.06 | 40.06 | 40.06 | 40.06 | 
| Reserves | 14,599.01 | 9,662.71 | 7,743.85 | 6,500.39 | 4,694.21 | 
| Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 
| Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 
| Total Shareholders Funds | 14,640.27 | 9,702.77 | 7,783.91 | 6,540.45 | 4,734.27 | 
| Secured Loans | 5,315.39 | 14.93 | 0.00 | 623.66 | 95.00 | 
| Unsecured Loans | 1,938.73 | 8.57 | 4.69 | 64.23 | 5.85 | 
| Total Debt | 7,254.12 | 23.50 | 4.69 | 687.89 | 100.85 | 
| Other Liabilities | 133.28 | 124.73 | 109.04 | 89.02 | 62.92 | 
| Total Liabilities | 22,027.67 | 9,851.00 | 7,897.64 | 7,317.36 | 4,898.04 | 
| APPLICATION OF FUNDS : | |||||
| Gross Block | 4,845.33 | 4,578.23 | 3,775.59 | 3,292.31 | 1,227.09 | 
| Less: Accumulated Depreciation | 1,374.58 | 1,026.67 | 633.37 | 365.62 | 239.68 | 
| Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 
| Net Block | 3,470.75 | 3,551.56 | 3,142.22 | 2,926.69 | 987.41 | 
| Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 
| Capital Work in Progress | 207.43 | 209.44 | 494.78 | 386.57 | 165.57 | 
| Investments | 16,683.38 | 4,215.36 | 3,102.23 | 2,525.87 | 2,396.89 | 
| Current Assets, Loans & Advances | |||||
| Inventories | 1,090.98 | 1,126.03 | 1,032.22 | 1,266.69 | 826.91 | 
| Sundry Debtors | 894.67 | 769.04 | 492.64 | 470.59 | 369.17 | 
| Cash and Bank Balance | 305.87 | 483.88 | 155.15 | 138.85 | 476.95 | 
| Loans and Advances | 845.63 | 1,011.09 | 775.44 | 1,070.80 | 520.92 | 
| Total Current Assets | 3,137.15 | 3,390.04 | 2,455.45 | 2,946.92 | 2,193.95 | 
| Less : Current Liabilities and Provisions | |||||
| Current Liabilities | 1,231.08 | 1,179.71 | 1,080.01 | 1,319.07 | 789.20 | 
| Provisions | 552.25 | 419.30 | 337.61 | 266.74 | 193.08 | 
| Total CL & Provisions | 1,783.33 | 1,599.01 | 1,417.62 | 1,585.81 | 982.28 | 
| Net Current Assets | 1,353.82 | 1,791.03 | 1,037.83 | 1,361.11 | 1,211.66 | 
| Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 
| Deferred Tax Assets | 398.21 | 358.15 | 263.37 | 165.26 | 122.49 | 
| Deferred Tax Liability | 415.53 | 424.53 | 319.23 | 200.79 | 109.45 | 
| Net Deferred Tax | -17.32 | -66.38 | -55.86 | -35.53 | 13.04 | 
| Other Assets | 329.61 | 149.99 | 176.45 | 152.67 | 123.47 | 
| Total Assets | 22,027.67 | 9,851.00 | 7,897.65 | 7,317.37 | 4,898.04 | 
| Contingent Liabilities | 1,193.31 | 247.00 | 78.72 | 135.24 | 15.79 |